<div id="readability-page-1"><p>CIBC Asset Management Inc trimmed its holdings in  McKesson Corporation (NYSE:MCK - Free Report) by 8.1% in the second quarter, according to its most recent disclosure with the Securities &amp; Exchange Commission. The institutional investor  owned 63,466 shares of the company's stock after selling 5,569 shares during the quarter. CIBC Asset Management Inc owned about 0.05% of McKesson worth $46,440,000 as of its most recent SEC filing.</p><ul><li>More Than Yield: 5 Stocks Beating the Market and Hiking Dividends</li></ul><p>Other hedge funds have also recently modified their holdings of the company. Brighton Jones LLC increased its holdings in shares of  McKesson by 46.3% in the 4th quarter. Brighton Jones LLC now owns 2,523 shares of the company's stock valued at $1,438,000 after acquiring an additional 798 shares during the period.  Independent Advisor Alliance increased its stake in  McKesson by 2.8% in the 1st quarter. Independent Advisor Alliance now owns 2,223 shares of the company's stock valued at $1,496,000 after buying an additional 60 shares during the period.  HighTower Advisors LLC boosted its holdings in shares of  McKesson by 2.0% in the first quarter. HighTower Advisors LLC now owns 73,868 shares of the company's stock valued at $49,712,000 after acquiring an additional 1,460 shares in the last quarter.  Callan Family Office LLC increased its stake in shares of  McKesson by 4.3% during the first quarter. Callan Family Office LLC now owns 842 shares of the company's stock worth $567,000 after acquiring an additional 35 shares during the period.  Finally, Dagco Inc. acquired a new position in shares of  McKesson during the first quarter worth about $47,000. 85.07% of the stock is owned by hedge funds and other institutional investors. </p><h2>McKesson Stock Up 2.4%</h2><p>MCK opened at $813.74 on Thursday. McKesson Corporation has a 52-week low of $558.13 and a 52-week high of $895.58. The firm's 50 day moving average is $817.57 and its 200-day moving average is $746.96. The firm has a market capitalization of $100.44 billion, a P/E ratio of 25.33, a P/E/G ratio of 1.31 and a beta of 0.38. </p><ul><li>3 Safe Dividend Stocks as Investors Seek to Reset Diversification</li></ul><p>McKesson (NYSE:MCK - Get Free Report) last posted its quarterly earnings results on Wednesday, November 5th. The company reported $9.86 EPS for the quarter, topping analysts' consensus estimates of $8.84 by $1.02. McKesson had a negative return on equity of 248.14% and a net margin of 1.04%.The business had revenue of $103.15 billion during the quarter, compared to the consensus estimate of $103.80 billion. During the same period last year, the firm earned $7.07 earnings per share. The company's revenue for the quarter was up 10.2% compared to the same quarter last year.  Equities analysts expect that  McKesson Corporation will post 32.77 earnings per share for the current fiscal year. </p><h2>McKesson Announces Dividend</h2><p>The business also recently declared a quarterly dividend, which will be paid on Friday, January 2nd. Stockholders of record on Monday, December 1st will be paid a $0.82 dividend. This represents a $3.28 dividend on an annualized basis and a dividend yield of 0.4%. The ex-dividend date of this dividend is Monday, December 1st. McKesson's dividend payout ratio  is currently 10.21%. </p><h2>Insider Transactions at McKesson</h2><ul><li> 3 Stocks to Consider With a Possible Recession on the Table</li></ul><p>In other news, CAO Napoleon B. Rutledge, Jr. sold 329 shares of the firm's stock in a transaction dated Friday, November 7th. The shares were sold at an average price of $861.63, for a total transaction of $283,476.27. Following the completion of the transaction, the chief accounting officer owned 328 shares in the company, valued at approximately $282,614.64. This trade represents a 50.08% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own  0.08% of the company's stock. </p><h2>Analysts Set New Price Targets</h2><p>MCK has been the subject of several recent analyst reports. Wall Street Zen cut shares of McKesson from a &#34;buy&#34; rating to a &#34;hold&#34; rating in a research note on Saturday, November 8th. JPMorgan Chase &amp; Co. raised their price target on McKesson from $821.00 to $853.00 and gave the company an &#34;overweight&#34; rating in a research report on Friday, September 26th. Deutsche Bank Aktiengesellschaft  reaffirmed a &#34;buy&#34; rating on shares of McKesson in a report on Wednesday. Evercore ISI  reissued an &#34;outperform&#34; rating and issued a $1,000.00 price target on shares of McKesson in a report on Thursday, November 6th. Finally, Weiss Ratings  restated a &#34;buy (a-)&#34; rating on shares of McKesson in a report on Monday. One investment analyst  has rated the stock with a Strong Buy rating, thirteen have given a Buy rating and four have issued  a Hold rating to the company's stock. According to MarketBeat, the stock  has a consensus rating of &#34;Moderate Buy&#34; and a consensus price target of $892.86.</p><p><b>Read Our Latest Analysis on McKesson</b></p><h2>McKesson Company Profile</h2> (Free Report)<p>McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than McKesson</li><li>The 3 Best Retail Stocks to Shop for in August</li><li>Market Momentum: 3 Stocks Poised for Major Breakouts</li><li>Health Care Stocks Explained: Why You Might Want to Invest</li><li>3 Reasons Casey’s General Stores Will Continue Trending Higher</li><li>Using the MarketBeat Stock Split Calculator</li><li>Golden Cross Alert: 3 Stocks With Major Upside Potential</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1DSw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPU1DSw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in McKesson Right Now?</h2><p>Before you consider McKesson, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and McKesson wasn't on the list.</p><p>While McKesson currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>CIBC Asset Management Inc reduced its stake in McKesson Corporation by 8.1% in Q2. McKesson's stock opened at $813.74, with a 52-week range of $558.13-$895.58. Analysts have adjusted ratings and price targets, with JPMorgan raising its target to $853.00. McKesson reported strong quarterly earnings, beating estimates, and announced a dividend of $0.82 per share. Insider transactions and institutional holdings are also highlighted.</p>

CIBC Asset Management Inc Reduces Stake in McKesson Corporation $MCK